Ignite Creation Date:
2024-05-06 @ 10:33 AM
Last Modification Date:
2024-10-26 @ 12:31 PM
Study NCT ID:
NCT03284177
Status:
COMPLETED
Last Update Posted:
2019-04-01
First Post:
2017-09-11
Brief Title:
A Trial of C13-CAC Breath Test in PPI Resistant GERD Patients
Sponsor:
Otsuka Pharmaceutical Co Ltd
Organization:
Otsuka Pharmaceutical Co Ltd
Study Overview
Official Title:
A Multicenter Open-label Trial to Investigate the Safety of C13-CAC and the Relationship Among C13-CAC Breath Test Gastric pH and the Improvement of Symptoms in PPI Resistant GERD Patients
Status:
COMPLETED
Status Verified Date:
2019-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate the safety of C13-CAC and the relationship among C13-CAC breath test gastric pH and the improvement of symptoms by switching PPI in PPI resistant GERD patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| JapicCTI-173713 | REGISTRY | Japic Clinical Trials Information | None |